UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 25, 2017
MEDICAL PROPERTIES TRUST, INC.
(Exact Name of Registrant as Specified in Charter)
Commission File Number 001-32559
| Maryland | 20-0191742 | |
| (State or other jurisdiction of incorporation or organization) |
(I. R. S. Employer Identification No.) | |
| 1000 Urban Center Drive, Suite 501 Birmingham, AL |
35242 | |
| (Address of principal executive offices) | (Zip Code) | |
Registrant’s telephone number, including area code
(205) 969-3755
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Section 5. Corporate Governance and Management.
| Item 5.07. | Submission of Matters to a Vote of Security Holders |
Our annual meeting of stockholders was held on May 25, 2017. The four proposals considered at the annual meeting were voted on as follows:
Proposal 1: The election of seven directors for the ensuing year. The number of votes cast for and against for each nominee for director along with the number of abstentions and broker non-votes is set forth below:
| Nominee: |
For: | Against: | Abstentions and Broker Non-Votes: |
|||||||||
| Edward K. Aldag, Jr. |
240,535,094 | 6,290,611 | 52,690,052 | |||||||||
| G. Steven Dawson |
240,788,819 | 6,025,088 | 52,701,850 | |||||||||
| R. Steven Hamner |
224,083,922 | 22,731,675 | 52,700,160 | |||||||||
| William G. McKenzie |
183,848,108 | 62,960,056 | 52,707,593 | |||||||||
| D. Paul Sparks, Jr. |
245,528,073 | 1,277,100 | 52,710,584 | |||||||||
| Michael G. Stewart |
245,086,311 | 1,724,833 | 52,704,613 | |||||||||
| C. Reynolds Thompson, III |
242,127,550 | 4,679,580 | 52,708,627 | |||||||||
Proposal 2: A proposal to ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2017. The number of votes that were cast for and against this proposal and the number of abstentions are set forth below:
| For: |
Against: |
Abstentions: | ||
| 294,629,872 |
3,932,547 | 953,338 |
Proposal 3: A proposal for an advisory resolution regarding executive compensation. The number of votes that were cast for and against this proposal and the number of abstentions and broker non-votes are set forth below:
| For: |
Against: |
Abstentions and Broker Non-Votes: | ||
| 231,356,060 |
14,787,831 | 53,371,866 |
Proposal 4: A proposal for an advisory resolution regarding the frequency of future advisory votes on executive officer compensation. The number of votes that were cast to conduct future votes on executive compensation for every 1-year, 2-years, 3-years or abstentions and broker non-votes are set forth below:
| 1-year: |
2-years: |
3-years: |
Abstentions and Broker Non-Votes: | |||
| 212,687,701 |
1,509,712 | 32,275,450 | 53,042,894 |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MEDICAL PROPERTIES TRUST, INC. | ||
| (Registrant) | ||
| By: | /s/ R. Steven Hamner | |
| R. Steven Hamner | ||
| Executive Vice President and Chief Financial Officer | ||
| Date: May 26, 2017 | ||